Related Experiment Videos
Economic implications of type 2 diabetes management
1carrie.mcadam-marx@pharm.utah.edu.
The American Journal of Managed Care
|July 13, 2013
Summary
Diabetes mellitus (DM) management faces challenges with rising costs and medication trends. Identifying unmet needs and reducing barriers are crucial for improving patient outcomes and managing this complex disease effectively.
Area of Science:
- Endocrinology
- Public Health
- Health Economics
Background:
- Diabetes mellitus (DM) presents significant morbidity, mortality, and escalating economic burden.
- Direct medical costs for DM have surged over fivefold between 1997 and 2012, driven by increased prevalence and care expenses.
- Trends indicate stable treatment proportions but shifts in anti-diabetic medication use, with less insulin-only therapy.
Purpose of the Study:
- To assess the current challenges in managing the growing population with diabetes mellitus.
- To highlight the economic impact and medication usage trends associated with DM.
- To emphasize the need for comprehensive unmet needs assessment for effective population management.
Main Methods:
- Analysis of American Diabetes Association (ADA) cost reports (1997-2012).
- Review of Centers for Disease Control (CDC) data on anti-diabetic medication usage (1997-2011).
- Examination of trends in DM prevalence, direct medical costs, and medication adherence.
Main Results:
- Direct medical costs for DM increased from $44 billion to $176 billion annually.
- Anti-diabetic medication trends show increased use of oral agents alone and stagnation in insulin uptake.
- Rising use of medications for comorbidities increases risks of errors, adverse events, and noncompliance.
Conclusions:
- Effective management of diabetes mellitus requires addressing challenges in care delivery and patient engagement.
- Identifying and mitigating barriers to optimal care are essential for improving population-level DM outcomes.
- A comprehensive approach to unmet needs is vital for proactive and successful diabetes management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...